Rebrozil subcutaneous injection 25mg by Bristol-Myers Squibb contains Ruspatercept (genetical recombination). This injectable drug, YJ code 3399417D1026, is supplied as 25mg per bottle and is indicated for the treatment of anemia in adult patients with beta thalassemia who require regular red blood cell transfusions.
Rebrozil subcutaneous injection 25mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →